In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Q: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Child Custody Protection Act''.

SEC. 2. TRANSPORTATION OF MINORS IN CIRCUMVENTION OF CERTAIN LAWS 
              RELATING TO ABORTION.

    Title 18, United States Code, is amended by inserting after chapter 
117 the following:

 ``CHAPTER 117A--TRANSPORTATION OF MINORS IN CIRCUMVENTION OF CERTAIN 
                       LAWS RELATING TO ABORTION

``Sec.
``2431. Transportation of minors in circumvention of certain laws 
                            relating to abortion.
``2432. Transportation of minors in circumvention of certain laws 
                            relating to abortion.
``Sec. 2431. Transportation of minors in circumvention of certain laws 
              relating to abortion
    ``(a) Offense.--
            ``(1) Generally.--Except as provided in subsection (b), 
        whoever knowingly transports a minor across a State line, with 
        the intent that such minor obtain an abortion, and thereby in 
        fact abridges the right of a parent under a law requiring 
        parental involvement in a minor's abortion decision, in force 
        in the State where the minor resides, shall be fined under this 
        title or imprisoned not more than one year, or both.
            ``(2) Definition.--For the purposes of this subsection, an 
        abridgement of the right of a parent occurs if an abortion is 
        performed or induced on the minor, in a State or a foreign 
        nation other than the State where the minor resides, without 
        the parental consent or notification, or the judicial 
        authorization, that would have been required by that law had 
        the abortion been performed in the State where the minor 
        resides.
    ``(b) Exceptions.--
            ``(1) The prohibition of subsection (a) does not apply if 
        the abortion was necessary to save the life of the minor 
        because her life was endangered by a physical disorder, 
        physical injury, or physical illness, including a life 
        endangering physical condition caused by or arising from the 
        pregnancy itself.
            ``(2) A minor transported in violation of this section, and 
        any parent of that minor, may not be prosecuted or sued for a 
        violation of this section, a conspiracy to violate this 
        section, or an offense under section 2 or 3 based on a 
        violation of this section.
    ``(c) Affirmative Defense.--It is an affirmative defense to a 
prosecution for an offense, or to a civil action, based on a violation 
of this section that the defendant--
            ``(1) reasonably believed, based on information the 
        defendant obtained directly from a parent of the minor, that 
        before the minor obtained the abortion, the parental consent or 
        notification took place that would have been required by the 
        law requiring parental involvement in a minor's abortion 
        decision, had the abortion been performed in the State where 
        the minor resides; or
            ``(2) was presented with documentation showing with a 
        reasonable degree of certainty that a court in the minor's 
        State of residence waived any parental notification required by 
        the laws of that State, or otherwise authorized that the minor 
        be allowed to procure an abortion.
    ``(d) Civil Action.--Any parent who suffers harm from a violation 
of subsection (a) may obtain appropriate relief in a civil action 
unless the parent has committed an act of incest with the minor subject 
to subsection (a).
    ``(e) Definitions.--For the purposes of this section--
            ``(1) the term `abortion' means the use or prescription of 
        any instrument, medicine, drug, or any other substance or 
        device intentionally to terminate the pregnancy of a female 
        known to be pregnant, with an intention other than to increase 
        the probability of a live birth, to preserve the life or health 
        of the child after live birth, to terminate an ectopic 
        pregnancy, or to remove a dead unborn child who died as the 
        result of a spontaneous abortion, accidental trauma or a 
        criminal assault on the pregnant female or her unborn child;
            ``(2) the term a `law requiring parental involvement in a 
        minor's abortion decision' means a law--
                    ``(A) requiring, before an abortion is performed on 
                a minor, either--
                            ``(i) the notification to, or consent of, a 
                        parent of that minor; or
                            ``(ii) proceedings in a State court; and
                    ``(B) that does not provide as an alternative to 
                the requirements described in subparagraph (A) 
                notification to or consent of any person or entity who 
                is not described in that subparagraph;
            ``(3) the term `minor' means an individual who is not older 
        than the maximum age requiring parental notification or 
        consent, or proceedings in a State court, under the law 
        requiring parental involvement in a minor's abortion decision;
            ``(4) the term `parent' means--
                    ``(A) a parent or guardian;
                    ``(B) a legal custodian; or
                    ``(C) a person standing in loco parentis who has 
                care and control of the minor, and with whom the minor 
                regularly resides, who is designated by the law 
                requiring parental involvement in the minor's abortion 
                decision as a person to whom notification, or from whom 
                consent, is required; and
            ``(5) the term `State' includes the District of Columbia 
        and any commonwealth, possession, or other territory of the 
        United States, and any Indian tribe or reservation.
``Sec. 2432. Transportation of minors in circumvention of certain laws 
              relating to abortion
    ``Notwithstanding section 2431(b)(2), whoever has committed an act 
of incest with a minor and knowingly transports the minor across a 
State line with the intent that such minor obtain an abortion, shall be 
fined under this title or imprisoned not more than one year, or both. 
For the purposes of this section, the terms `State', `minor', and 
`abortion' have, respectively, the definitions given those terms in 
section 2435.''.

SEC. 3. CLERICAL AMENDMENT.

    The table of chapters at the beginning of part I of title 18, 
United States Code, is amended by inserting after the item relating to 
chapter 117 the following new items:

``117A. Transportation of minors in circumvention of certain    2431''.
                            laws relating to abortion.

A: Child Custody Protection Act - Amends the federal criminal code to prohibit transporting a minor child across a state line to obtain an abortion (deems such transporting to be a de facto abridgment of the right of a parent under any law in the minors state of residence that requires parental involvement in the minors abortion decision). Makes an exception for an abortion necessary to safe the life of the minor.

Makes it an affirmative defense to a prosecution or civil action under this Act that a defendant: (1) reasonably believed that before the minor obtained the abortion, the required parental consent or notification or judicial authorization took place; or (2) was presented with documentation showing that a court waived parental notification requirements or authorized the minor's abortion.

Defines "abortion" as the termination of a pregnancy with an intention other than to increase the probability of a live birth, preserve the life or health of the child after live birth, terminate an ectopic pregnancy, or remove a dead unborn child who died as the result of a spontaneous abortion, accidental trauma, or a criminal assault on the pregnant female or her unborn child.

Imposes a fine and/or prison term of up to one year on anyone who has committed an act of incest with a minor and knowingly transports such minor across a state line to obtain an abortion.
****
Q: SECTION 1. FINDINGS.

    Congress finds that--
            (1) the historical significance of the 52-mile Going-to-
        the-Sun Road in Glacier National Park, Montana, is recognized 
        by its--
                    (A) listing on the National Register of Historic 
                Places in 1983;
                    (B) designation as a National Historic Engineering 
                Landmark by the American Society of Civil Engineers in 
                1985; and
                    (C) designation as a National Historic Landmark in 
                1997;
            (2) in 1997, recommendations of the Federal Highway 
        Administration concerning, and an engineering study of, the 
        Road verified significant structural damage to the Road has 
        occurred since the Road opened in 1932;
            (3) infrastructure at most of the developed areas in the 
        Park is inadequate for cold-season (fall, winter, and spring) 
        operation, and maintenance backlog needs exist for normal 
        summer operation;
            (4) the Many Glacier Hotel and Lake McDonald Lodge are on 
        the National Register of Historic Places and are National 
        Historic Landmarks;
            (5) other accommodations operated by the concessionaire 
        that have possessory interest and are listed on the National 
        Register of Historic Places are the Rising Sun Motor Inn and 
        Swiftcurrent Motel;
            (6) the historic hotels in the Park, operated under 
        concession agreements with the National Park Service, are 
        essential for public use and enjoyment of the Park;
            (7) visitors to the Park deserve safe hotels in the Park 
        that meet basic needs and expectations;
            (8) the historic hotels in the Park have deteriorated 
        significantly and need substantial repair;
            (9) repairs of the hotels in the Park have been deferred 
        for so long that, absent any changes to the Federal law 
        governing concessionaires and the availability of historic tax 
        credits for up to 39.5 years, the remodeling costs for the 
        hotels exceed the capacity of the hotel concessionaire to 
        finance the repairs with hotel revenues;
            (10) the remodeling costs of Park hotels are so high that 
        the concessionaire will need to finance the cost of those 
        repairs by borrowing the remodeling expenses and repaying them 
        over time out of net hotel income, which by current law is 
        limited to 20-year concession agreements;
            (11) the season of operation for hotels is about 4 months 
        because the developed areas of the Park lack--
                    (A) water, sewer, and fire protection systems that 
                can operate in freezing conditions;
                    (B) building insulation; and
                    (C) heating systems;
            (12) because of many factors, including the high projected 
        costs of remodeling, the relatively short tourist season in the 
        Park, and the requirement that concession agreements may not 
        exceed 20 years, concessionaires are unable to carry out the 
        scope of remodeling that is needed for the hotels in the Park;
            (13) the National Park Service Concessions Management 
        Improvement Act of 1998 (16 U.S.C. 5951 et seq.) is based on 
        sound principles and is achieving its basic purposes, but there 
        appear to be selected instances in which the National Park 
        Service needs additional authority to conduct demonstration 
        projects; and
            (14) a demonstration project is needed to carry out repairs 
        of the historic hotels in the Park.

SEC. 2. DEFINITIONS.

    In this Act:
            (1) Committee.--The term ``Committee'' means the Going-to-
        the-Sun Road Citizens' Advisory Committee.
            (2) Park.--The term ``Park'' means Glacier National Park, 
        Montana.
            (3) Road.--The term ``Road'' means Going-to-the-Sun Road, 
        located in the Park.
            (4) Secretary.--The term ``Secretary'' means the Secretary 
        of the Interior.

SEC. 3. GOING-TO-THE-SUN ROAD FEASIBILITY STUDY AND REHABILITATION 
              PLAN.

    (a) Feasibility Study.--
            (1) In general.--Not later than June 30, 2001, the 
        Secretary, in consultation with the Committee, shall complete a 
        feasibility study for rehabilitation of the Road.
            (2) Inclusions.--The feasibility study shall include--
                    (A) alternative plans for rehabilitation of the 
                Road, including--
                            (i) a ranking of the feasibility of each 
                        plan;
                            (ii) an estimate of the length of time 
                        necessary to complete each plan;
                            (iii) a description of which mitigation 
                        efforts would be used to preserve resources and 
                        minimize adverse economic effects of each plan;
                            (iv) an analysis of the costs and benefits 
                        of each plan;
                            (v) an estimate of the cost of each plan;
                    (B) an analysis of long-term maintenance needs, 
                standards, and schedules for the Road, alternatives to 
                accomplish the work, maintenance staff needs, and 
                associated cost estimates; and
                    (C) a complete environmental analysis that meets 
                any applicable requirement of--
                            (i) the National Environmental Policy Act 
                        of 1969 (42 U.S.C. 4321 et seq.);
                            (ii) the National Historic Preservation Act 
                        (16 U.S.C. 470 et seq.); and
                            (iii) any other applicable law.
            (3) Submission.--Not later than 30 days after completion of 
        the feasibility study, the Secretary shall submit to the 
        Committee on Resources in the House of Representatives and the 
        Committee on Energy and Natural Resources in the Senate a copy 
        of the study.
    (b) Rehabilitation Plan.--
            (1) In general.--As soon as practicable after completing 
        the study and environmental analysis under subsection (a), the 
        Secretary shall--
                    (A) consider the recommendations of the Committee;
                    (B) make any decision documented in the 
                environmental analysis process; and
                    (C) select and implement a rehabilitation plan for 
                the Road.
            (2) Authorized actions.--In implementing a rehabilitation 
        plan under this subsection, the Secretary may--
                    (A) use funds to--
                            (i) rehabilitate the Road; and
                            (ii) carry out transportation system 
                        improvements or impact mitigation activities 
                        outside the Park, if recommended in the 
                        feasibility study and by the Committee; and
                    (B) seek funding for any long-term maintenance 
                needs identified in the feasibility study.
            (3) Authorization of appropriations.--There is authorized 
        to be appropriated to the Secretary to implement the 
        rehabilitation plan (including the cost of any necessary 
        environmental or cultural documentation and monitoring), 
        $200,000,000.
    (c) Continuation of Maintenance.--Nothing in this section affects 
the duty of the Secretary to continue the program in effect on the day 
before the date of the enactment of this Act to preserve, maintain, and 
address safety concerns relating to the Road.

SEC. 4. MAINTENANCE AND UPGRADE OF UTILITY
              SYSTEMS.

    (a) In General.--As soon as practicable after funds are made 
available under this section, the Secretary shall begin the upgrade and 
continue the maintenance of utility systems that serve the Park and 
facilities relating to the Park.
    (b) Authorization of Appropriations.--There is authorized to be 
appropriated to the Secretary to carry out this section, $20,000,000.

SEC. 5. HOTEL REHABILITATION.

    (a) Competitive Leases of Property.--Notwithstanding section 3(k) 
of Public Law 91-383 (commonly known as the ``National Park System 
General Authorities Act'') (16 U.S.C. 1a-2) or any other provision of 
law, subject to subsection (b), the Secretary may enter into a 
competitive lease of Federal property in the Park under which a lessee 
may provide visitor services to visitors to the area.
    (b) Mandatory Conditions of Leases.--
            (1) In general.--The Secretary shall enter into a lease 
        under subsection (a) only after determining that the provision 
        of visitor services--
                    (A) is necessary and appropriate for the 
                accommodation of visitors to the Park, taking into 
                consideration the value of providing additional visitor 
                services (including conference facilities) for groups 
                of visitors in the early spring and late fall months, 
                especially as those additional services may provide 
                extra revenue needed to finance improvements for the 
                historic hotels in Glacier National Park; and
                    (B) is consistent with section 402 of the National 
                Park Service Concessions Management Improvement Act of 
                1998 (16 U.S.C. 5952).
            (2) Terms and conditions.--The Secretary shall include in a 
        lease under this subsection appropriate terms and conditions to 
        ensure, to the maximum extent practicable, that--
                    (A) any visitor service provided is--
                            (i) adequate; and
                            (ii) available at a reasonable rate--
                                    (I) to be approved by the Secretary 
                                in accordance with section 406 of the 
                                National Park Service Concessions 
                                Management Improvement Act of 1998 (16 
                                U.S.C. 5951 et seq.); and
                                    (II) that may be at such a level as 
                                to allow any investment in capital 
                                improvements for visitor services to be 
                                recovered within a reasonable amount of 
                                time by the concessionaire that 
                                financed the improvements;
                    (B) the leased property will be properly maintained 
                by the lessee, and, with respect to historic property 
                that may be leased, preserved, and maintained in a 
                manner consistent with the historic character of the 
                property, as determined by the Secretary; and
                    (C) assure the lessee of adequate protection 
                against any loss of investment in an improvement to 
                real property that the lessee may make to the leased 
                property (including an obligation of the United States 
                to compensate the lessee for any loss of investment in 
                an improvement to real property in any circumstances 
                that the Secretary determines to be prudent).
    (c) Leasehold Surrender Value.--In any contract for improvements, 
the Secretary shall recognize the leasehold surrender value of any 
existing lease that the Secretary may require to be surrendered in any 
action that is associated with approving an improvement to visitor 
services under this section.

A: Directs the Secretary to upgrade and continue the maintenance of utility systems which service the Park and its related facilities. Authorizes appropriations.
Authorizes the Secretary to enter into competitive leases of federally-owned property in the Park under which the lessee will be authorized to provide visitor services (including a hotel), subject to specified conditions.
****
Q: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Preservation of Antibiotics for 
Medical Treatment Act of 2011''.

SEC. 2. FINDINGS.

    The Congress finds the following:
            (1) In January 2001, a Federal interagency task force--
                    (A) released an action plan to address the 
                continuing decline in effectiveness of antibiotics 
                against common bacterial infections, referred to as 
                antibiotic resistance;
                    (B) determined that antibiotic resistance is a 
                growing menace to all people and poses a serious threat 
                to public health; and
                    (C) cautioned that if current trends continue, 
                treatments for common infections will become 
                increasingly limited and expensive, and, in some cases, 
                nonexistent.
            (2) Antibiotic resistance, resulting in a reduced number of 
        effective antibiotics, may significantly impair the ability of 
        the United States to respond to terrorist attacks involving 
        bacterial infections or a large influx of hospitalized 
        patients.
            (3)(A) Any overuse or misuse of antibiotics contributes to 
        the spread of antibiotic resistance, whether in human medicine 
        or in agriculture.
            (B) Recognizing the public health threat caused by 
        antibiotic resistance, Congress took several steps to curb 
        antibiotic overuse in human medicine through amendments to the 
        Public Health Service Act (42 U.S.C. 201 et seq.) made by 
        section 102 of the Public Health Threats and Emergencies Act 
        (Public Law 106-505, title I; 114 Stat. 2315), but has not yet 
        addressed antibiotic overuse in agriculture.
            (4) In a March 2003 report, the National Academy of 
        Sciences stated that--
                    (A) a decrease in antimicrobial use in human 
                medicine alone will have little effect on the current 
                situation; and
                    (B) substantial efforts must be made to decrease 
                inappropriate overuse in animals and agriculture.
            (5) In 2010, the FDA determined that--
                    (A) 13.1 million kilograms of antibacterial drugs 
                were sold for use on food animals in the United States 
                in 2009;
                    (B) 3.3 million kilograms of antibacterial drugs 
                were used for human health in 2009; and
                    (C) therefore, 80 percent of antibacterial drugs 
                disseminated in the United States in 2009 were sold for 
                use on food animals, rather than being used for human 
                health.
            (6)(A) Large-scale, voluntary surveys by the Department of 
        Agriculture's Animal and Plant Health Inspection Service in 
        1999, 2001, and 2006 revealed that--
                    (i) 84 percent of grower-finisher swine farms, 83 
                percent of cattle feedlots, and 84 percent of sheep 
                farms administer antimicrobials in the feed or water 
                for health or growth promotion reasons; and
                    (ii) many of the antimicrobials identified are 
                identical or closely related to drugs used in human 
                medicine, including tetracyclines, macrolides, 
                Bacitracin, penicillins, and sulfonamides; and
            (B) these drugs are used in people to treat serious 
        diseases such as pneumonia, scarlet fever, rheumatic fever, 
        venereal disease, skin infections, and even pandemics like 
        malaria and plague, as well as bioterrorism agents like 
        smallpox and anthrax.
            (7) Many scientific studies confirm that the nontherapeutic 
        use of antibiotics in agricultural animals contributes to the 
        development of antibiotic-resistant bacterial infections in 
        people.
            (8) The periodical entitled ``Clinical Infectious 
        Diseases'' published a report in June 2002, that--
                    (A) was based on a 2-year review by experts in 
                human and veterinary medicine, public health, 
                microbiology, biostatistics, and risk analysis, of more 
                than 500 scientific studies on the human health impacts 
                of antimicrobial use in agriculture; and
                    (B) recommended that antimicrobial agents should no 
                longer be used in agriculture in the absence of 
                disease, but should be limited to therapy for diseased 
                individual animals and prophylaxis when disease is 
                documented in a herd or flock.
            (9) The United States Geological Survey reported in March 
        2002 that--
                    (A) antibiotics were present in 48 percent of the 
                streams tested nationwide; and
                    (B) almost half of the tested streams were 
                downstream from agricultural operations.
            (10) An April 1999 study by the General Accounting Office 
        concluded that resistant strains of 3 microorganisms that cause 
        food-borne illness or disease in humans (Salmonella, 
        Campylobacter, and E. coli) are linked to the use of 
        antibiotics in animals.
            (11) Epidemiological research has shown that resistant 
        Salmonella and Campylobacter infections are associated with 
        increased numbers of ill patients and bloodstream infections, 
        and increased death.
            (12) In 2010, the peer-reviewed journal Molecular Cell 
        published a study demonstrating that low-dosage use of 
        antibiotics causes a dramatic increase in genetic mutation, 
        raising new concerns about the agricultural practice of using 
        low-dosage antibiotics in order to stimulate growth promotion 
        and routinely prevent disease in unhealthy conditions.
            (13)(A) In January 2003, Consumer Reports published test 
        results on poultry products bought in grocery stores nationwide 
        showing disturbingly high levels of Campylobacter and 
        Salmonella bacteria that were resistant to the antibiotics used 
        to treat food-borne illnesses.
            (B) The Food and Drug Administration's National 
        Antimicrobial Resistance Monitoring System routinely finds that 
        retail meat products are contaminated with bacteria (including 
        the foodborne pathogens Campylobacter and Salmonella) that are 
        resistant to antibiotics important in human medicine.
            (C) In December 2007, the USDA issued a fact sheet on the 
        recently recognized link between antimicrobial drug use in 
        animals and Methicillin Resistant Staphylococcus Aureas (MRSA) 
        infections in humans.
            (14) In October 2001, the New England Journal of Medicine 
        published an editorial urging a ban on nontherapeutic use of 
        medically important antibiotics in animals.
            (15)(A) In 1998, the National Academy of Sciences noted 
        that antibiotic-resistant bacteria generate a minimum of 
        $4,000,000,000 to $5,000,000,000 in costs to United States 
        society and individuals yearly.
            (B) In 2009, Cook County Hospital and the Alliance for 
        Prudent Use of Antibiotics estimated that the total health care 
        cost of antibiotic resistant infections in the United States 
        was between $16,600,000,000 and $26,000,000,000 annually.
            (16) The American Medical Association, the American Public 
        Health Association, the National Association of County and City 
        Health Officials, and the National Campaign for Sustainable 
        Agriculture are among the more than 300 organizations 
        representing health, consumer, agricultural, environmental, 
        humane, and other interests that have supported enactment of 
        legislation to phase out nontherapeutic use in farm animals of 
        medically important antibiotics.
            (17) In 2010, the Danish Veterinary and Food Administration 
        testified that the Danish ban of the non-therapeutic use of 
        antibiotics in food animal production resulted in a marked 
        reduction in antimicrobial resistance in multiple bacterial 
        species, including Campylobacter and Enterococci.
            (18) In 2009, the Congressional Research Service concluded 
        that restrictions overseas on the use of antimicrobial drugs in 
        the production of livestock could impact U.S. export markets 
        for livestock and poultry.
            (19) The Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
        301 et seq.)--
                    (A) requires that all drugs be shown to be safe 
                before the drugs are approved; and
                    (B) places the burden on manufacturers to account 
                for health consequences and prove safety.
            (20)(A) The Food and Drug Administration recently modified 
        the drug approval process for antibiotics to recognize the 
        development of resistant bacteria as an important aspect of 
        safety, but most antibiotics currently used in animal 
        production systems for nontherapeutic purposes were approved 
        before the Food and Drug Administration began considering 
        resistance during the drug-approval process.
            (B) The Food and Drug Administration has not established a 
        schedule for reviewing those existing approvals.
            (21) Certain non-routine uses of antibiotics in animal 
        agriculture are legitimate to prevent animal disease.
            (22) An April 2004 study by the General Accounting Office--
                    (A) concluded that Federal agencies do not collect 
                the critical data on antibiotic use in animals that 
                they need to support research on human health risks; 
                and
                    (B) recommends that the Department of Agriculture 
                and the Department of Health and Human Services develop 
                and implement a plan to collect data on antibiotic use 
                in animals.

SEC. 3. PURPOSE.

    The purpose of this Act is to preserve the effectiveness of 
medically important antibiotics used in the treatment of human and 
animal diseases by reviewing the safety of certain antibiotics for 
nontherapeutic purposes in food-producing animals.

SEC. 4. PROOF OF SAFETY OF CRITICAL ANTIMICROBIAL ANIMAL DRUGS.

    (a) Definitions.--Section 201 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 321) is amended by adding at the end the 
following:
    ``(ss) Critical Antimicrobial Animal Drug.--The term `critical 
antimicrobial animal drug' means a drug that--
            ``(1) is intended for use in food-producing animals; and
            ``(2) is composed wholly or partly of--
                    ``(A) any kind of penicillin, tetracycline, 
                macrolide, lincosamide, streptogramin, aminoglycoside, 
                or sulfonamide; or
                    ``(B) any other drug or derivative of a drug that 
                is used in humans or intended for use in humans to 
                treat or prevent disease or infection caused by 
                microorganisms.
    ``(tt) Nontherapeutic Use.--The term `nontherapeutic use', with 
respect to a critical antimicrobial animal drug, means any use of the 
drug as a feed or water additive for an animal in the absence of any 
clinical sign of disease in the animal for growth promotion, feed 
efficiency, weight gain, routine disease prevention, or other routine 
purpose.''.
    (b) Applications Pending or Submitted After Enactment.--Section 
512(d)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
360b(d)(1)) is amended--
            (1) in the first sentence--
                    (A) in subparagraph (H), by striking ``or'' at the 
                end;
                    (B) in subparagraph (I), by inserting ``or'' at the 
                end; and
                    (C) by inserting after subparagraph (I) the 
                following:
                    ``(J) with respect to a critical antimicrobial 
                animal drug or a drug of the same chemical class as a 
                critical antimicrobial animal drug, the applicant has 
                failed to demonstrate that there is a reasonable 
                certainty of no harm to human health due to the 
                development of antimicrobial resistance that is 
                attributable, in whole or in part, to the 
                nontherapeutic use of the drug; or''; and
            (2) in the second sentence, by striking ``(A) through (I)'' 
        and inserting ``(A) through (J)''.
    (c) Phased Elimination of Nontherapeutic Use in Animals of Critical 
Antimicrobial Animal Drugs Important for Human Health.--Section 512 of 
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b) is amended by 
adding at the end the following:
    ``(q) Phased Elimination of Nontherapeutic Use in Animals of 
Critical Antimicrobial Animal Drugs Important for Human Health.--
            ``(1) Applicability.--This subsection applies to the 
        nontherapeutic use in a food-producing animal of a drug--
                    ``(A)(i) that is a critical antimicrobial animal 
                drug; or
                    ``(ii) that is of the same chemical class as a 
                critical antimicrobial animal drug; and
                    ``(B)(i) for which there is in effect an approval 
                of an application or an exemption under subsection (b), 
                (i), or (j) of section 505; or
                    ``(ii) that is otherwise marketed for use.
            ``(2) Withdrawal.--The Secretary shall withdraw the 
        approval of a nontherapeutic use in food-producing animals 
        described in paragraph (1) on the date that is 2 years after 
        the date of enactment of this subsection unless--
                    ``(A) before the date that is 2 years after the 
                date of the enactment of this subsection, the Secretary 
                makes a final written determination that the holder of 
                the approved application has demonstrated that there is 
                a reasonable certainty of no harm to human health due 
                to the development of antimicrobial resistance that is 
                attributable in whole or in part to the nontherapeutic 
                use of the drug; or
                    ``(B) before the date specified in subparagraph 
                (A), the Secretary makes a final written determination 
                under this subsection, with respect to a risk analysis 
                of the drug conducted by the Secretary and other 
                relevant information, that there is a reasonable 
                certainty of no harm to human health due to the 
                development of antimicrobial resistance that is 
                attributable in whole or in part to the nontherapeutic 
                use of the drug.
            ``(3) Exemptions.--Except as provided in paragraph (5), if 
        the Secretary grants an exemption under section 505(i) for a 
        drug that is a critical antimicrobial animal drug, the 
        Secretary shall rescind each approval of a nontherapeutic use 
        in a food-producing animal of the critical antimicrobial animal 
        drug, or of a drug in the same chemical class as the critical 
        antimicrobial animal drug, as of the date that is 2 years after 
        the date on which the Secretary grants the exemption.
            ``(4) Approvals.--Except as provided in paragraph (5), if 
        an application for a drug that is a critical antimicrobial 
        animal drug is submitted to the Secretary under section 505(b), 
        the Secretary shall rescind each approval of a nontherapeutic 
        use in a food-producing animal of the critical antimicrobial 
        animal drug, or of a drug in the same chemical class as the 
        critical antimicrobial animal drug, as of the date that is 2 
        years after the date on which the application is submitted to 
        the Secretary.
            ``(5) Exception.--Paragraph (3) or (4), as the case may be, 
        shall not apply if--
                    ``(A) before the date on which approval would be 
                rescinded under that paragraph, the Secretary makes a 
                final written determination that the holder of the 
                application for the approved nontherapeutic use has 
                demonstrated that there is a reasonable certainty of no 
                harm to human health due to the development of 
                antimicrobial resistance that is attributable in whole 
                or in part to the nontherapeutic use in the food-
                producing animal of the critical antimicrobial animal 
                drug; or
                    ``(B) before the date specified in subparagraph 
                (A), the Secretary makes a final written determination 
                under this subsection, with respect to a risk analysis 
                of the critical antimicrobial animal drug conducted by 
                the Secretary and any other relevant information, that 
                there is a reasonable certainty of no harm to human 
                health due to the development of antimicrobial 
                resistance that is attributable in whole or in part to 
                the nontherapeutic use of the drug.''.

SEC. 5. COMMITTEE HEARINGS ON IMPLEMENTATION.

    (a) In General.--The Committee on Energy and Commerce of the House 
of Representatives and the Committee on Energy of the Senate shall each 
hold a hearing on the implementation by the Commissioner of Food and 
Drugs of section 512(q) of the Federal Food, Drug, and Cosmetic Act, as 
added by section 4 of this Act.
    (b) Exercise of Rulemaking Authority.--Subsection (a) is enacted--
            (1) as an exercise of the rulemaking power of the House of 
        Representatives and Senate, and, as such, they shall be 
        considered as part of the rules of the House or Senate (as the 
        case may be), and such rules shall supersede any other rule of 
        the House or Senate only to the extent that rule is 
        inconsistent therewith; and
            (2) with full recognition of the constitutional right of 
        either House to change such rules (so far as relating to the 
        procedure in such House) at any time, in the same manner, and 
        to the same extent as in the case of any other rule of the 
        House or Senate.

A:
Preservation of Antibiotics for Medical Treatment Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services (HHS) to deny an application for a new animal drug that is a critical antimicrobial animal drug unless the applicant demonstrates that there is a reasonably certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Defines "critical antimicrobial animal drug" as a drug intended for use in food-producing animals that contains specified antibiotics or other drugs used in humans to treat or prevent disease or infection caused by microorganisms.

Requires the Secretary to withdraw approval of a nontherapeutic use of such drugs in food-producing animals two years after the date of enactment of this Act unless certain safety requirements are met. Directs specified congressional committees to hold hearings on the implementation of such a withdrawal of approval.
****